Tomorrow Health raises $25 million

Home medical equipment provider Tomorrow Health has closed a $25 million Series A round of funding led by Andreessen Horowitz with participation from Obvious Ventures and BoxGroup. In addition, the company announced Paul Mango, former Deputy Chief of Staff for Policy at HHS and Roy Beveridge, former Chief Medical Officer at Humana, have joined its Advisory Board.

The NYC-based company led by co-founder and CEO Vijay Kedar (formerly senior director of care innovation at Oscar Health) and co-founder and CTO Gabriel Flateman (formerly co-founder and CTO of Casper) was established in 2018 to operate in the space of home-based care. Partnering with payors, referring providers, and durable medical equipment (DME) suppliers, Tomorrow Health provides a data-driven intelligence platform to match patients with high-quality DME suppliers based on insurance coverage, service quality, geography, and product specialization. Its team of Care Advocates offer support throughout the process, ensuring equipment and supplies are delivered when and where they are needed.

“We believe the home should be a patient’s primary point of care, and we are focused on providing patients with the right products, guidance and support to make that a reality. One size does not fit all in healthcare or medical equipment. From walkers and rollators after a fall, to oxygen concentrators and respiratory supplies for COPD and ongoing recovery from COVID-19, it is essential that patients receive equipment tailored to their conditions with speed and reliability. We are committed to getting each patient’s individual needs fulfilled in partnership with the highest-quality suppliers and to removing the stress and complexity that have become synonymous with navigating at-home care.” – Vijay Kedar, co-founder and Chief Executive Officer of Tomorrow Health.

“The home health space is still living in the Dark Ages and desperately needs an upgrade. Tomorrow Health is setting a new, patient-first standard for how we improve the process. Their holistic solution tackles each fragmented step of home healthcare and connects it all in one place. The platform’s critical technology infrastructure offers increased visibility and value to payors, provides tools for operational efficiency for DME suppliers, and saves providers and their staff time spent on coordination so they can focus on patient care.” – Julie Yoo, General Partner at Andreessen Horowitz, who is joining the company’s board.

“From a population health standpoint, there are few areas of greater importance than the safe transition of patients to home-based healthcare. During a critical and often stressful time for patients and caregivers, the patient-first mentality of the Tomorrow Health platform delivers an unprecedented level of care that supports patients and their families as they navigate their home-based healthcare needs.” – Roy Beveridge, former Humana Chief Medical Officer.

Since its public launch in April 2020, Tomorrow Health has partnered with more than 125 health plans and hospital systems.